Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia

被引：0
作者：
Dakota Gustafson
Jason E. Fish
Jeffrey H. Lipton
Nazanin Aghel
机构：
[1] University of Toronto,Department of Laboratory Medicine and Pathobiology
[2] University Health Network,Peter Munk Cardiac Centre
[3] Toronto General Hospital Research Institute University Health Network,Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre
[4] University Health Network,Division of Cardiology, Juravinski Cancer Centre
[5] University of Toronto,undefined
[6] McMaster University,undefined
来源：
Current Hematologic Malignancy Reports | 2020年 / 15卷
关键词：
Cardiovascular; Tyrosine kinase inhibitors; Endothelial; Inflammation; Biomarker; Endothelium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：20 / 30
页数：10
相关论文
共 977 条
[1]  
Höglund M(2015)Epidemiology of chronic myeloid leukemia: an update Ann Hematol 94 241-247
[2]  
Sandin F(2012)Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy Cancer 118 3123-3127
[3]  
Simonsson B(2015)Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV Blood 126 42-49
[4]  
Huang X(2016)Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial The Lancet Oncology 17 612-621
[5]  
Cortes J(2015)Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia Journal of Clinical Oncology 33 4210-4218
[6]  
Kantarjian H(2017)Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance Vasc Health Risk Manag 13 293-1343
[7]  
Saußele Susanne(2015)The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries Leukemia 29 1336-2405
[8]  
Krauß Marie-Paloma(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood. 127 2391-S1S8
[9]  
Hehlmann Rüdiger(2015)Mutations in the BCR-ABL1 kinase domain and elsewhere in chronic myeloid leukemia Clin Lymphoma Myeloma Leuk 15 S120-217
[10]  
Lauseker Michael(2008)BCR-ABL in chronic myelogenous leukemia--how does it work? Acta Haematol 119 212-187
12345678910